Medicus Pharma Stock Current Valuation
| MDCX Stock | 3.95 0.25 6.76% |
Valuation analysis of Medicus Pharma helps investors to measure Medicus Pharma's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Medicus Pharma's Cash is fairly stable compared to the past year. Change In Cash is likely to climb to about 1.5 M in 2024, whereas Begin Period Cash Flow is likely to drop slightly above 264.1 K in 2024. Fundamental drivers impacting Medicus Pharma's valuation include:
Price Book 9.3998 | Enterprise Value 39.6 M |
Overvalued
Today
Please note that Medicus Pharma's price fluctuation is extremely dangerous at this time. Calculation of the real value of Medicus Pharma is based on 3 months time horizon. Increasing Medicus Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Medicus stock is determined by what a typical buyer is willing to pay for full or partial control of Medicus Pharma. Since Medicus Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medicus Stock. However, Medicus Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.95 | Real 3.66 | Hype 3.55 | Naive 4.61 |
The intrinsic value of Medicus Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medicus Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Medicus Pharma helps investors to forecast how Medicus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medicus Pharma more accurately as focusing exclusively on Medicus Pharma's fundamentals will not take into account other important factors: Medicus Pharma Company Current Valuation Analysis
Medicus Pharma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Medicus Pharma Current Valuation | 39.63 M |
Most of Medicus Pharma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medicus Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Medicus Pharma has a Current Valuation of 39.63 M. This is much higher than that of the sector and significantly higher than that of the Current Valuation industry. The current valuation for all Canada stocks is notably lower than that of the firm.
Medicus Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medicus Pharma's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medicus Pharma could also be used in its relative valuation, which is a method of valuing Medicus Pharma by comparing valuation metrics of similar companies.Medicus Pharma is currently under evaluation in current valuation category among its peers.
Medicus Fundamentals
| Current Valuation | 39.63 M | |||
| Shares Outstanding | 11.82 M | |||
| Number Of Shares Shorted | 900 | |||
| Price To Book | 9.40 X | |||
| Net Income | (6.78 M) | |||
| Total Debt | 1.09 M | |||
| Cash Flow From Operations | (4.16 M) | |||
| Short Ratio | 0.96 X | |||
| Earnings Per Share | (1.25) X | |||
| Target Price | 5.61 | |||
| Market Capitalization | 46.68 M | |||
| Total Asset | 1.89 M | |||
| Retained Earnings | (19.18 M) | |||
| Working Capital | 805.8 K | |||
| Net Asset | 1.89 M |
About Medicus Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medicus Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medicus Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medicus Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medicus Stock Analysis
When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.